QIAGEN launches QIAsymphony Connect nucleic acid extraction platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
August 27, 2026 4:05 PM EDTNew IVD automation platform standardizes nucleic acid extraction across diverse assay workflows with improved productivity, sample traceability and process safety Builds on more than 3,300 cumulative placements of the established QIAsymphony platform while using the same QIAsymphony kits and consumables Supports high-growth applications such as liquid biopsy
VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid... More
